Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.65 - $2.92 $2 Million - $3.54 Million
-1,213,361 Reduced 98.7%
15,927 $28,000
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $1.94 Million - $2.89 Million
1,038,004 Added 542.65%
1,229,288 $3.33 Million
Q4 2023

Feb 14, 2024

BUY
$1.59 - $2.73 $76,771 - $131,815
48,284 Added 33.77%
191,284 $422,000
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $271,700 - $436,150
143,000 New
143,000 $414,000
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $39,248 - $97,874
24,530 New
24,530 $39,000
Q4 2020

Feb 16, 2021

SELL
$5.45 - $8.65 $1.15 Million - $1.82 Million
-210,600 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.34 - $11.43 $914,004 - $2.41 Million
210,600 New
210,600 $2,000
Q2 2020

Aug 14, 2020

SELL
$1.85 - $5.29 $49,580 - $141,772
-26,800 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$1.24 - $4.35 $117,800 - $413,249
-95,000 Reduced 78.0%
26,800 $68,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $5.12 $490,819 - $1.09 Million
-213,400 Reduced 63.66%
121,800 $424,000
Q3 2019

Nov 14, 2019

SELL
$4.63 - $12.15 $1.21 Million - $3.18 Million
-261,500 Reduced 43.82%
335,200 $1.55 Million
Q2 2019

Aug 14, 2019

SELL
$11.49 - $14.17 $6.39 Million - $7.88 Million
-555,900 Reduced 48.23%
596,700 $7.35 Million
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $1.67 Million - $2.83 Million
196,900 Added 20.6%
1,152,600 $15.3 Million
Q4 2018

Feb 14, 2019

BUY
$7.18 - $8.83 $3.81 Million - $4.68 Million
530,300 Added 124.66%
955,700 $8.24 Million
Q3 2018

Nov 14, 2018

BUY
$5.92 - $8.35 $742,368 - $1.05 Million
125,400 Added 41.8%
425,400 $3.19 Million
Q2 2018

Aug 14, 2018

BUY
$4.86 - $6.24 $731,400 - $939,082
150,494 Added 100.66%
300,000 $1.79 Million
Q1 2018

May 15, 2018

BUY
$5.75 - $7.97 $859,659 - $1.19 Million
149,506 New
149,506 $873,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.